ArticleMolecular pharmaceutics2024

Immunotherapy Study on Non-small-Cell Lung Cancer (NSCLC) Combined with Cytotoxic T Cells and miRNA34a.

Richa Pandey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.